2 ml of solution contain
- Active ingredient – phospholipids of the hypothalamus 28 mg,
- Excipients: mannitol, sodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, p-hydroxybenzoic acid esters, water for injection.
Metabolic processes administered parenterally have been studied both in terms of assessing total radioactivity and at the cellular level. Research data show that the molecules are stable in the blood and reach brain cells.
Parenteral administration of hypothalamic phospholipids can activate hypothalamic metabolism by increasing the turnover of dopamine, tyrosine hydroxylase, and adenylate cyclase, followed by accumulation of cyclic AMP. This pharmacological action is reflected especially in the function of the hypothalamus-pituitary gland.
Influencing the physicochemical properties of neuronal membranes, hypothalamic phospholipids change the adaptation of central neuron receptors to treatment.
Indications for use
- Adjunct in the treatment of metabolic cerebral disorders due to neuroendocrine disorders.
Dosage and administration
Liposome forte is administered 2 ml intramuscularly or intravenously once a day.
The course of treatment is determined by the doctor individually.
No adverse side effects were found.
If you experience side effects that are not prescribed in the instructions, you should consult a doctor.
– allergic reactions (skin itch, urticaria, rash)
– Established hypersensitivity to the components of the drug
– the presence of infection or damage to the skin in the area injections
Clinically significant interaction of the drug with other drugs has not been established. Liposome forte can be administered simultaneously with other pharmaceutical products and, in particular, with neuroleptics, drugs against hyperprolactinemia, tricyclic antidepressants (reduces delay of action and increases efficiency) and cardiac drugs.
The drug does not entail any special warnings and precautions for use.
Do not use the drug with a damaged or opened package.
Application in pediatrics
The drug is not recommended for use in children due to the lack of data on the safety and efficacy of use in pediatrics.
Pregnancy and lactation
During pregnancy and lactation (breastfeeding), the drug should be used under the strict supervision of a physician.
Features of the effect of the drug on the ability to drive vehicles and potentially dangerous mechanisms
Liposome forte does not affect a person’s ability to drive vehicles, engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.
There were no symptoms of overdose when treated with recommended doses.
In case of accidental overdose, treatment is symptomatic.
Store below 25°C.
Keep out of the reach of children!
Shelf life – 2 years
Do not use after the expiration date indicated on the package.